127 related articles for article (PubMed ID: 32147356)
21. Interaction studies of novel cell selective antimicrobial peptides with model membranes and E. coli ATCC 11775.
Joshi S; Bisht GS; Rawat DS; Kumar A; Kumar R; Maiti S; Pasha S
Biochim Biophys Acta; 2010 Oct; 1798(10):1864-75. PubMed ID: 20599694
[TBL] [Abstract][Full Text] [Related]
22. Incorporation of β-Amino Acids Enhances the Antifungal Activity and Selectivity of the Helical Antimicrobial Peptide Aurein 1.2.
Lee MR; Raman N; Gellman SH; Lynn DM; Palecek SP
ACS Chem Biol; 2017 Dec; 12(12):2975-2980. PubMed ID: 29091404
[TBL] [Abstract][Full Text] [Related]
23. Controls and constrains of the membrane disrupting action of Aurein 1.2.
Shahmiri M; Enciso M; Mechler A
Sci Rep; 2015 Nov; 5():16378. PubMed ID: 26574052
[TBL] [Abstract][Full Text] [Related]
24. The effect of membrane curvature on the conformation of antimicrobial peptides: implications for binding and the mechanism of action.
Chen R; Mark AE
Eur Biophys J; 2011 Apr; 40(4):545-53. PubMed ID: 21267557
[TBL] [Abstract][Full Text] [Related]
25. Alignment-based design and synthesis of new antimicrobial Aurein-derived peptides with improved activity against Gram-negative bacteria and evaluation of their toxicity on human cells.
Madanchi H; Akbari S; Shabani AA; Sardari S; Farmahini Farahani Y; Ghavami G; Ebrahimi Kiasari R
Drug Dev Res; 2019 Feb; 80(1):162-170. PubMed ID: 30593676
[TBL] [Abstract][Full Text] [Related]
26. NMR studies of aurein 1.2 analogs.
Li X; Li Y; Peterkofsky A; Wang G
Biochim Biophys Acta; 2006 Sep; 1758(9):1203-14. PubMed ID: 16716252
[TBL] [Abstract][Full Text] [Related]
27. The antibiotic and anticancer active aurein peptides from the Australian Bell Frogs Litoria aurea and Litoria raniformis the solution structure of aurein 1.2.
Rozek T; Wegener KL; Bowie JH; Olver IN; Carver JA; Wallace JC; Tyler MJ
Eur J Biochem; 2000 Sep; 267(17):5330-41. PubMed ID: 10951191
[TBL] [Abstract][Full Text] [Related]
28. Membrane interaction and secondary structure of de novo designed arginine-and tryptophan peptides with dual function.
Rydberg HA; Carlsson N; Nordén B
Biochem Biophys Res Commun; 2012 Oct; 427(2):261-5. PubMed ID: 22989747
[TBL] [Abstract][Full Text] [Related]
29. Design of short membrane selective antimicrobial peptides containing tryptophan and arginine residues for improved activity, salt-resistance, and biocompatibility.
Saravanan R; Li X; Lim K; Mohanram H; Peng L; Mishra B; Basu A; Lee JM; Bhattacharjya S; Leong SS
Biotechnol Bioeng; 2014 Jan; 111(1):37-49. PubMed ID: 23860860
[TBL] [Abstract][Full Text] [Related]
30. Design and characterization of novel antimicrobial peptides, R-BP100 and RW-BP100, with activity against Gram-negative and Gram-positive bacteria.
Torcato IM; Huang YH; Franquelim HG; Gaspar D; Craik DJ; Castanho MA; Troeira Henriques S
Biochim Biophys Acta; 2013 Mar; 1828(3):944-55. PubMed ID: 23246973
[TBL] [Abstract][Full Text] [Related]
31. Interaction of antimicrobial peptides from Australian amphibians with lipid membranes.
Marcotte I; Wegener KL; Lam YH; Chia BC; de Planque MR; Bowie JH; Auger M; Separovic F
Chem Phys Lipids; 2003 Jan; 122(1-2):107-20. PubMed ID: 12598042
[TBL] [Abstract][Full Text] [Related]
32. Truncated and constrained helical analogs of antimicrobial esculentin-2EM.
Pham TK; Kim DH; Lee BJ; Kim YW
Bioorg Med Chem Lett; 2013 Dec; 23(24):6717-20. PubMed ID: 24211019
[TBL] [Abstract][Full Text] [Related]
33. Biophysical studies on the antimicrobial activity of linearized esculentin 2EM.
Malik E; Phoenix DA; Badiani K; Snape TJ; Harris F; Singh J; Morton LHG; Dennison SR
Biochim Biophys Acta Biomembr; 2020 Feb; 1862(2):183141. PubMed ID: 31790693
[TBL] [Abstract][Full Text] [Related]
34. Understanding interactions of Citropin 1.1 analogues with model membranes and their influence on biological activity.
Rodrigues de Almeida N; Catazaro J; Krishnaiah M; Singh Chhonker Y; Murry DJ; Powers R; Conda-Sheridan M
Peptides; 2019 Sep; 119():170119. PubMed ID: 31336137
[TBL] [Abstract][Full Text] [Related]
35. Solution structure and model membrane interactions of temporins-SH, antimicrobial peptides from amphibian skin. A NMR spectroscopy and differential scanning calorimetry study.
Abbassi F; Galanth C; Amiche M; Saito K; Piesse C; Zargarian L; Hani K; Nicolas P; Lequin O; Ladram A
Biochemistry; 2008 Oct; 47(40):10513-25. PubMed ID: 18795798
[TBL] [Abstract][Full Text] [Related]
36. Solid-state NMR study of antimicrobial peptides from Australian frogs in phospholipid membranes.
Balla MS; Bowie JH; Separovic F
Eur Biophys J; 2004 Apr; 33(2):109-16. PubMed ID: 13680211
[TBL] [Abstract][Full Text] [Related]
37. Proline-15 creates an amphipathic wedge in maculatin 1.1 peptides that drives lipid membrane disruption.
Sani MA; Lee TH; Aguilar MI; Separovic F
Biochim Biophys Acta; 2015 Oct; 1848(10 Pt A):2277-89. PubMed ID: 26079051
[TBL] [Abstract][Full Text] [Related]
38. Role of molecular architecture on the relative efficacy of aurein 2.5 and modelin 5.
Dennison SR; Morton LH; Phoenix DA
Biochim Biophys Acta; 2012 Sep; 1818(9):2094-102. PubMed ID: 22617856
[TBL] [Abstract][Full Text] [Related]
39. Discovery of two bombinin peptides with antimicrobial and anticancer activities from the skin secretion of Oriental fire-bellied toad, Bombina orientalis.
Zhou C; Wang Z; Peng X; Liu Y; Lin Y; Zhang Z; Qiu Y; Jin M; Wang R; Kong D
Chem Biol Drug Des; 2018 Jan; 91(1):50-61. PubMed ID: 28636781
[TBL] [Abstract][Full Text] [Related]
40. Comparison of reversible membrane destabilisation induced by antimicrobial peptides derived from Australian frogs.
Lee TH; Heng C; Separovic F; Aguilar MI
Biochim Biophys Acta; 2014 Sep; 1838(9):2205-15. PubMed ID: 24593995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
